Clinical trials: Brainstem Glioma
Diffuse Intrinsic Pontine Glioma, High-grade Glioma
Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
This is a phase I study to find the highest tolerable dose of crizotinib and dasatinib given in combination to patients with diffuse intrinsic pontine glioma (DIPG) and other types of high grade gliomas (HGG).
- Trial name
- NCT01644773
- Testing
- Crizotinib, Dasatinib
- Where
- United States
- Volunteers
- 36 people
- Sponsor
- St. Jude Children's Research Hospital